Skip to main content
ALMR
NASDAQ Industrial Applications And Services

Director and Illumina Funds Disclose 9.6% Stake in Alamar Biosciences Post-IPO

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Medical Device Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$23.79
Mkt Cap
$1.63B
52W Low
$21.75
52W High
$25.028
52W Position info
9.4% above low
Off High info
4.9% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

ALMR is trading near its 52-week low of $21.75 (9.4% above the low) on light trading volume (0.4× avg).

Summary

Illumina Innovation Funds and Director Nicholas Naclerio have disclosed a 9.6% beneficial ownership in Alamar Biosciences, Inc. post-IPO, representing a significant stake valued at over $151 million.


Key Events · Ownership and Investor Activity · ALMR

  • Significant Ownership Disclosure

    Illumina Innovation Fund II, L.P., Illumina Innovation Fund III, L.P., and Director Nicholas Naclerio collectively reported beneficial ownership of 6,363,612 shares, representing 9.6% of Alamar Biosciences' common stock.

  • Post-IPO Stake

    This substantial ownership was established following the company's initial public offering, with shares acquired through the conversion of preferred stock and convertible notes, and a direct purchase in the IPO.

  • Director Involvement

    Nicholas Naclerio, a director of Alamar Biosciences, Inc., is the sole managing member of the general partners for both Illumina Innovation Funds, linking the significant institutional stake directly to an insider.

  • Lock-Up Agreement

    The reporting persons are subject to a 180-day lock-up agreement, restricting the sale or transfer of their shares for that period, which provides near-term stability.


Analysis · ALMR · Industrial Applications And Services

This initial Schedule 13D filing reveals that Illumina Innovation Funds and Director Nicholas Naclerio collectively hold a substantial 9.6% beneficial ownership in Alamar Biosciences, Inc. following its recent IPO. The significant stake, valued at over $151 million, signals strong conviction from a key pre-IPO investor and an insider. The reporting persons are also subject to a 180-day lock-up agreement, providing near-term stability for the stock. This disclosure comes as the company's stock trades near its 52-week high, reflecting positive market reception post-IPO.

At the time of this filing, ALMR was trading at $23.79 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $1.6B. The 52-week trading range was $21.75 to $25.03. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

ALMR - Latest Insights

ALMR
Jul 13, 2026, 2:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $28.42
Real-time Price: $24.40 info
Change: -$4.02 (-14%) info
Market Cap: $1.691B info
ALMR
Jul 07, 2026, 4:55 PM EDT
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $25.23
Real-time Price: $24.40 info
Change: -$0.830 (-3%) info
Market Cap: $1.691B info
ALMR
May 08, 2026, 8:30 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $24.16
Real-time Price: $24.40 info
Change: +$0.240 (+0.99%) info
Market Cap: $1.691B info
ALMR
May 08, 2026, 8:05 AM EDT
Filing Type: 8-K
Importance Score:
9
Price at Filing: $24.16
Real-time Price: $24.40 info
Change: +$0.240 (+0.99%) info
Market Cap: $1.691B info
ALMR
Apr 23, 2026, 1:57 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $23.71
Real-time Price: $24.40 info
Change: +$0.690 (+3%) info
Market Cap: $1.691B info